Research progress on the immune microenvironment and immunotherapy in gastric cancer

Front Immunol. 2023 Nov 23:14:1291117. doi: 10.3389/fimmu.2023.1291117. eCollection 2023.

Abstract

The tumor microenvironment, particularly the immune microenvironment, plays an indispensable role in the malignant progression and metastasis of gastric cancer (GC). As our understanding of the GC microenvironment continues to evolve, we are gaining deeper insights into the biological mechanisms at the single-cell level. This, in turn, has offered fresh perspectives on GC therapy. Encouragingly, there are various monotherapy and combination therapies in use, such as immune checkpoint inhibitors, adoptive cell transfer therapy, chimeric antigen receptor T cell therapy, antibody-drug conjugates, and cancer vaccines. In this paper, we review the current research progress regarding the GC microenvironment and summarize promising immunotherapy research and targeted therapies.

Keywords: gastric cancer; immune microenvironment; immunity; immunotherapy; single-cell sequencing.

Publication types

  • Review

MeSH terms

  • Humans
  • Immunoconjugates*
  • Immunotherapy
  • Immunotherapy, Adoptive
  • Stomach Neoplasms* / therapy
  • Tumor Microenvironment

Substances

  • Immunoconjugates

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.